Sue Desmond-Hellmann: A smarter, more precise way to think about public health
Sue Desmond-Hellmann: Toplum sağlığı hakkında düşünmenin daha akıllıca, daha hassas bir yolu
Sue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person. Full bio
Double-click the English transcript below to play the video.
Theresa Marie.
and Kevin Michael's on his right.
sağındaki Kevin Michael.
was picking names.
şeylerden biriyse isim seçmekti.
number seven came along,
isimleri tüketmiştik.
on Jennifer Bridget.
ismine karar vermenin
ceremonial moment.
bölgesinde ebeveynlerin
for their new babies
of this special ceremonial time?
anların tadını çıkarmıyorlar?
bearable without a name.
biraz daha katlanılır olabilir.
dreaming of the future of that child --
hayalleriyle dolu bir zaman;
of a future for their child
geleceğini hayal etmeye
an updated pie chart.
diyagram gördüğümü hatırlıyorum.
nedenleri" ismiyle etiketlenmişti.
under five worldwide."
of that pie chart, about 40 percent --
bir parçası vardı, yaklaşık yüzde 40.
etiketlenmişti.
is less than one month old.
olduğunu anlatan bir sıfat.
"We have no idea."
"Hiçbir fikrimiz yok" idi.
what you can't define.
bir şeyi düzeltemezsin.
the dreams of those parents
korumada ilk görevimiz
about a new approach,
hakkında konuşmak istiyorum,
öldüğünü anlamamıza
know why babies are dying,
bütün global sağlığı
from a very special place.
çok özel bir yerden geliyor.
an oncologist.
olarak eğitim aldım.
to help people feel better.
hissetmelerini sağlamak istiyorum.
made them feel worse.
daha kötü hissetmelerine neden oluyor.
being driven to my clinic
tarafından getirilen genç bayanları
into my exam room by their mothers.
yardımına muhtaç yetişkinler.
in the war on cancer,
ön saflarda savaşacak
couldn't differentiate
that we wanted to hit hard
kanser hücreleriyle,
that we wanted to preserve.
hücreleri ayırt edemiyordu.
all very familiar with --
so infection was a constant threat --
ve sürekli bir enfeksiyon riski--
to the biotechnology industry.
endüstrisine geçtim.
for breast cancer patients
kanser hücrelerini ayırt etmede
of telling the healthy cells
yeni bir yaklaşım üzerinde
HER2-positive breast cancer,
çeşidi olan HER2-pozitif göğüs kanserini
form of breast cancer.
hit hard the cancer cells,
hücrelere daha nazik davranırken
gentle on the normal cells.
gene sequencing and more --
araçtan faydalanarak
mücadele edebiliyoruz.
alabilme imkânı sunuyor.
revolutionized cancer therapy.
terapisini baştan yarattı.
better way to tackle diseases
daha iyi yolu sadece zengin kesimin
expensive medicines like Herceptin
ilaçları gelişmekte olan
targeting for individuals
you're thinking, "She's crazy.
diye düşünüyorsunuz.
bir şekilde yapıyoruz
to make a big difference.
yaratmaya başladı bile.
as a cancer doctor.
eğitildiğimi söyledim.
who trained in San Francisco in the '80s,
görmüş sayısız doktor gibi ben de
olarak eğitim aldım.
a terrible global challenge.
global sorun olmaya devam ediyor.
are living with HIV.
17 milyon kadın HIV ile yaşıyor.
become pregnant,
until the age of two.
bile ulaşamadan ölüyor.
can virtually guarantee
terapi annenin bebeğe
the virus to the baby.
neredeyse garanti edebiliyor.
kind of like that blast of chemo,
tıpkı kemoterapi patlaması gibi,
every pregnant woman in the world.
test edip terapiye almak olur.
where HIV rates are the highest.
olduğu bölgeleri hedef almalıyız.
in sub-Saharan Africa
Afrika ülkelerinde
where rates are highest.
kadınları test edip tedavi edebiliriz.
to a public health problem
olan hassas yaklaşım
in certain areas in the developing world
bölgelerinde hamile kadınları gözlemlemek
can change things on a big scale.
yaratabileceğine güçlü bir örnek.
alacağımızı biliyoruz.
elements of precision public health:
sağlığının önemli yönleri:
to the 2.6 million babies
the causes of infant mortality
gerçekleştiği ülkelerde
with the highest infant mortality
belirleme yöntemimiz
who has just lost her child,
yeni kaybetmiş anneye soruyor:
Did they have a fever?"
after the baby has died.
in the shoes of that mom.
excruciating conversation.
işkence eden bir konuşma.
there was a fever or vomiting,
veya kustuğunu bilebiliriz,
that knowledge,
a precision public health approach?
yaklaşımını uyguluyor olsaydık?
because of a bacterial infection
bakteriyel enfeksiyon
enfeksiyonu yüzünden.
mom has a seven times higher chance
bir sonraki çocuğunun ölme ihtimali
we can prevent that death
penisilin kadar ucuz ve güvenli
and safe as penicillin.
o zaman biliyor oluruz.
the right interventions
müdahaleleri doğru yerlerde,
in the right places
and with these interventions
our 15-year goal.
ulaşmasını sağlayabiliriz.
into a million babies' lives saved
hayatının kurtulmasına
to public health --
çok daha güçlü bir yaklaşım --
tackle malnutrition?
biçimde mücadele edemeyelim?
cervical cancer in women?
kanserini önleyemeyelim?
in two different worlds,
farklı dünyada yaşıyorum.
by public health professionals.
toplum sağlık görevlileriyle.
iki farklı dünyada yaşıyoruz:
about precision public health
en heyecanlı olduğum konu ise
talent and tools --
ortaya çıkarıyoruz --
in ways I never imagined
yollarla hastalıkları hedef almak
that kind of talent and tools
ve araçları fakir dünyada
durdurmak için kullanabiliriz.
the confidence
the moment that child is born,
özgüvene sahip olur.
will be measured in decades,
değil, yıllarla hesaplanacağı
ABOUT THE SPEAKER
Sue Desmond-Hellmann - CEO, Gates FoundationSue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person.
Why you should listen
As CEO of the Bill & Melinda Gates Foundation, Sue Desmond-Hellmann leads the organization's vision for a world where every person has the opportunity to live a healthy, productive life. Drawing on her diverse experience as scientist, physician and business executive, she oversees a variety of missions focused on eradicating disease, poverty and inequity. She leads 1,400 people, across four continents, working in more than 100 countries to help more children and young people survive and thrive, combat infectious diseases that hit the poorest hardest, and empower people -- particularly women and girls -- to transform their lives.
Trained as an oncologist, Dr. Desmond-Hellmann spent 14 years at biotech firm Genentech, developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. In November 2009, Forbes magazine named her one of the world's seven most "powerful innovators," calling her "a hero to legions of cancer patients." Her time at Genentech put her at the forefront of the precision medicine revolution, and in her current role she champions a similar approach to global development: precision public health -- getting the right interventions, to the right populations, in the right places, to save lives.
Immediately prior to joining the foundation in 2014, Dr. Desmond-Hellmann was the first female chancellor of the University of California at San Francisco (UCSF), overseeing all aspects of the university and medical center's strategy and operations. It was her second stint at UCSF, having completed her clinical training there in the 1980s. She moved to Uganda in 1989 to work on HIV/AIDS and cancer, which she credits as a turning point in her career. "It was so profound to recognize ... that all the learning I had done to become a doctor didn't matter at all if I didn’t make a contribution," she said.
Dr. Desmond-Hellmann is the recipient of numerous honors and awards. She was listed among Fortune magazine's "50 most powerful women in business" for seven years. In 2010, she was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine. She serves on the boards of directors at Facebook Inc. and the Procter & Gamble Company.
Sue Desmond-Hellmann | Speaker | TED.com